Grants and contracts awarded to Yale School of Medicine

March/April 2006


  • Frederick Altice, NIH, Improving Health Outcomes for Released HIV+ Prisoners, 2 years, $411,339
  • Lynn Cooley, NIH, Olympus DSU Confocal System, 1 year, $132,523
  • Richard Ehrenkranz, NIH, NICHD Cooperative Multi-Center Neonatal Research Network, 5 years, $1,193,506
  • Cynthia Epperson, NIH, Sex, GABA and Nicotine: A 1H-MRS Study, 5 years, $1,495,069
  • Erol Fikrig, NIH, Tissue-Specific Borrelia Gene Expression, 5 years, $2,043,750
  • Elena Grigorenko, NIH, Genetic Bases of Developmental Language Disorders, 5 years, $3,009,794
  • Stephanie Halene, NIH, Role of C/EBP epsilon in Myeloid Differentiation, 5 years, $646,311
  • Lyndsay Harris, U.S. Department of Defense, Molecular Classifications of Response to Therapy in HER2-Positive, Early Stage Breast Cancer, 2 years, $994,847
  • Christina Herrick, NIH, Th2 Responses in the Cutaneous Environment, 5 years, 1,839,375
  • Leonard Kaczmarek, NIH, Expression of Ion Channels in the Auditory System, 5 years, $1,737,190
  • Arie Kaffman, NIH, Effect of Maternal Care on Neurogenesis and Behavior, 5 years, $911,347
  • Anthony Koleske, NIH, A Biochemical Screen for Novel Regulators of Neuronal Morphogenesis, 2 years, $404,663
  • William Konigsberg, NIH, Molecular Biology and Structure of DNA Replicase, 4 years, $1,324,949
  • James Leckman, NIH, Treatment of Tourette’s Syndrome and Obsessive-Compulsive Disorder, 5 years, $641,520
  • Luis Marenco, NIH, Mediated Integration of Neuroscience Resources, 3 years, $995,103
  • Ruth Montgomery, NIH, Mechanism of Vector Saliva Inhibition of Innate Immunity, 2 years, $449,625
  • Peter Moore, NIH, Program in Macromolecular Structure, Motion, Control, 3 years, $4,563,043
  • Xenophon Papademetris, NIH, Bioimage Suite: A Structural, Functional, and Metabolic Image Analysis Platform, 4 years, $1,466,357
  • David Rothstein, NIH, Immune Tolerance to Transplanted Myoblasts, 5 years, 1,541,450
  • Jody Sindelar, NIH, Work Life, Health Habits, and Health: Longitudinal Analysis, 4 years, $1,717,006
  • Scott Strobel, NSF, Riboswitch Structure Function Analysis, 1 year, $244,881
  • Joann Sweasy, NIH, Characterization of a DNA Polymerase Beta–Deficient Mouse, 5 years, $1,451,065
  • Benjamin Turk, U.S. Department of the Army, Identification of Substrates and Inhibitors of the Anthrax Lethal Factor, 1 year, $259,928

  • Hervé Agaisse, Edward Mallinckrodt, Jr. Foundation, Identification of Host Factors Involved in Intracellular Pathogen Infection, 1 year, $60,000
  • Fengwei Bai, Health Research Inc., Lentivirus Mediated Delivery ofWest NileVirus sRNA Therapeutics, 1 year, $53,309
  • Nancy Berliner, Robert Leet and Clara Guthrie Patterson Trust, Disruption of Myelopoiesis by Human Anaplasma Infection, 1 year, $62,500
  • Michael Bracken, University of Vermont, Cochrane Neonatal Review Group (CNRG), 5 years, $42,814
  • Kathleen Carroll, University of California–Los Angeles, Starting Treatment with Agonist Replacement (START), 17 months, $1,368,000
  • Marie Egan, Cystic Fibrosis Foundation, Bone Marrow–Derived Stem Cells: Potential Use in CF, 2 years, $194,400
  • Brian Elbel, Russell Sage Foundation, Choice Sets and Consumer Selection of Health Plans, 1 year, $4,639
  • Lyndsay Harris, CALGB Foundation, RNA Profiling from Paraffin in CALGB 934219840, 1 year, $101,057
  • Josephine Hoh, Verto Institute, LLC, Genome-Wide Linkage Disequilibrium Mapping for Carcinoid Susceptibility, 2 years, $234,000; Macula Vision Research Foundation, Age-Related Macular Degeneration Susceptibility Genes, 3 years, $240,000
  • Peter Jatlow, University of Connecticut Health Center, Urine Cotinine Safety Testing, 1 year, $29,120
  • Harriet Kluger, Novogen Limited, Assessing the Activity and Mechanism of Action of NV-143 and NV-196 in Melanoma, 1 year, $57,225
  • Charles Lockwood, March of Dimes, Abruption-Induced Preterm Delivery Effects Functional Endometrial Progesterone Withdrawal, 3 years, $483,101
  • Linda Marc, Connecticut Health Foundation, Recruiting, Retaining, and Promoting URM Faculty at YSPH, 18 months, $30,000
  • Angus Nairn, Rockefeller University, Drugs of Abuse—Role of Protein Phosphorylation: Three Striatal Phosphoproteins and Actions of Psychostimulants, 5 years, $256,444
  • Laura Niklason, Columbia University, Engineering Vascularized Cardiac Muscle, 6 months, $125,000
  • Errol Norwitz, March of Dimes, Progesterone Receptor Dysregulation and Preterm Birth, 3 years, $371,586
  • Scott Rivkees, JS Genetics, Newborn Screening for Sex Chromosome Disorders, 1 year, $50,588
  • Susumu Tomita, Edward Mallinckrodt, Jr. Foundation, Molecular Mechanism for Excitatory Synaptic Plasticity in the Brain, 1 year, $60,000
  • Marianne Ulcickas Yood, Henry Ford Health System, The HMO Cancer Research Network (CRN), 1 year, $13,003
  • Flora Vaccarino, Tourette Syndrome Association, Inc., Inhibitory Interneurons in Tourette’s Syndrome, 1 year, $74,195
  • Hong Wang, American Cancer Society, Inc., The Impact of the Penetration of Domestic-Made Foreign-Brand Cigarettes on Tobacco Consumption in China, 2 years, $40,000